KURT VON EMSTER Transaction History

Date Transaction Value Shares Traded Form
Jul 31 2017
SELL
Open market or private sale
$91,892 $17.51 p/Share
5,248
Jul 28 2017
SELL
Open market or private sale
$7,060 $17.65 p/Share
400
Jul 27 2017
SELL
Open market or private sale
$720,869 $17.62 p/Share
40,912
Jul 26 2017
SELL
Open market or private sale
$418,607 $17.63 p/Share
23,744
Jul 25 2017
SELL
Open market or private sale
$160,939 $17.52 p/Share
9,186
Jul 14 2017
SELL
Open market or private sale
$609,389 $16.82 p/Share
36,230
Jul 13 2017
SELL
Open market or private sale
$567,321 $16.87 p/Share
33,629
Jul 12 2017
SELL
Open market or private sale
$296,675 $16.6 p/Share
17,872
Jul 11 2017
SELL
Open market or private sale
$233,262 $16.52 p/Share
14,120
Jul 05 2017
SELL
Open market or private sale
$69,170 $16.26 p/Share
4,254
Jun 29 2017
SELL
Open market or private sale
$191,797 $16.52 p/Share
11,610
Jun 28 2017
SELL
Open market or private sale
$538,328 $17.04 p/Share
31,592
Jun 27 2017
SELL
Open market or private sale
$582,755 $17.43 p/Share
33,434
Jun 26 2017
SELL
Open market or private sale
$807,857 $16.83 p/Share
48,001
Jun 23 2017
SELL
Open market or private sale
$500,549 $16.23 p/Share
30,841
Jun 22 2017
SELL
Open market or private sale
$24,753 $16.21 p/Share
1,527
Oct 24 2016
BUY
Open market or private purchase
$784,000 $14.0 p/Share
56,000
Oct 24 2016
BUY
Conversion of derivative security
-
2,545,814

Also insider at

PCVX
Vaxcyte, Inc. Healthcare
CBAY
CymaBay Therapeutics, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
JSPR
Jasper Therapeutics, Inc. Healthcare
KVE

Kurt Von Emster

Director
Foster City, CA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP